MRK Insider Trading
Insider Ownership Percentage: 0.09%
Insider Buying (Last 12 Months): $250,012.25
Insider Selling (Last 12 Months): $209,562.36
Merck & Co., Inc. Insider Trading History Chart
This chart shows the insider buying and selling history at Merck & Co., Inc. by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Merck & Co., Inc. Share Price & Price History
Current Price: $88.06
Price Change: ▲ Price Increase of +0.188 (0.21%)
As of 03/26/2025 04:59 PM ET
Merck & Co., Inc. Insider Trading History
Merck & Co., Inc. Institutional Trading History
Data available starting January 2016
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Read More on Merck & Co., Inc.
Today's Range
Now: $88.06
52 Week Range
Now: $88.06
Volume
13,807,591 shs
Average Volume
10,310,121 shs
Market Capitalization
$222.44 billion
P/E Ratio
13.08
Dividend Yield
3.42%
Beta
0.35
Who are the company insiders with the largest holdings of Merck & Co., Inc.?
Merck & Co., Inc.'s top insider shareholders include:
- Robert M Davis (CEO)
- Richard R Deluca (EVP)
- Rita A Karachun (VP)
- Steven Mizell (EVP)
- Joseph Romanelli (Insider)
- Johannes Jacobus Oosthuizen (Insider)
- Cristal N Downing (Insider)
- Inge G Thulin (Director)
- Sanat Chattopadhyay (Insider)
Learn More about top insider investors at Merck & Co., Inc..
Who are the major institutional investors of Merck & Co., Inc.?
Which institutional investors are selling Merck & Co., Inc. stock?
During the previous quarter, MRK stock was sold by these institutional investors:
- FMR LLC
- Price T Rowe Associates Inc. MD
- Capital World Investors
- Amundi
- DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main
- Legal & General Group Plc
- Ameriprise Financial Inc.
- International Assets Investment Management LLC
Which institutional investors are buying Merck & Co., Inc. stock?
During the last quarter, MRK stock was acquired by institutional investors including:
- Norges Bank
- Bank of New York Mellon Corp
- Wellington Management Group LLP
- Northern Trust Corp
- Dimensional Fund Advisors LP
- Franklin Resources Inc.
- UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
- Invesco Ltd.
Within the previous year, these company insiders have bought Merck & Co., Inc. stock:
- Robert M Davis (CEO)
- Richard R Deluca (EVP)
Learn More investors buying Merck & Co., Inc. stock.